194 related articles for article (PubMed ID: 37546414)
1. Identification and comprehensive analysis of epithelial-mesenchymal transition related target genes of miR-222-3p in breast cancer.
Fang Y; Zhang Q; Chen C; Chen Z; Zheng R; She C; Zhang R; Wu J
Front Oncol; 2023; 13():1189635. PubMed ID: 37546414
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer.
Fang Y; Zhang Q; Chen Z; Guo C; Wu J
Aging (Albany NY); 2024 Jan; 16(1):322-347. PubMed ID: 38189813
[TBL] [Abstract][Full Text] [Related]
3. Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1.
Pan X; Hong X; Lai J; Cheng L; Cheng Y; Yao M; Wang R; Hu N
Front Oncol; 2020; 10():441. PubMed ID: 32426266
[TBL] [Abstract][Full Text] [Related]
4. Identification of Serum miR-501-3p and miR-338-3p as Novel Diagnostic Biomarkers for Breast Cancer and Their Target Genes Associated with Immune Infiltration.
Yin L; Ding Y; Wang Y; Wang C; Sun K; Wang L
Int J Gen Med; 2023; 16():1279-1294. PubMed ID: 37077765
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA CNOT2 knockdown regulates twist family BHLH transcription factor via targeting microRNA 409-3p to prevent breast cancer invasion, migration and epithelial-mesenchymal transition.
Su Q; Shen H; Gu B; Zhu N
Bioengineered; 2021 Dec; 12(1):9058-9069. PubMed ID: 34698000
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K/AKT pathway.
Yan T; Ye XX
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5139-5148. PubMed ID: 31298367
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
[TBL] [Abstract][Full Text] [Related]
9. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
Fan X; Huang X; Li Z; Ma X
J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
[TBL] [Abstract][Full Text] [Related]
11. LINC01433/miR-2116-3p/MYC Feedback Loop Promotes Cell Proliferation, Migration, and the Epithelial-Mesenchymal Transition in Breast Cancer.
Wu M; Wu W; Ding J; Yang J
Cancer Biother Radiopharm; 2019 Aug; 34(6):388-397. PubMed ID: 30939038
[No Abstract] [Full Text] [Related]
12. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971
[TBL] [Abstract][Full Text] [Related]
13. MiR-337-3p suppresses migration and invasion of breast cancer cells by downregulating ESRP1.
Pan Y; Zhao Y; Lihui L; Xie Y; Zou Q
Acta Histochem; 2021 Oct; 123(7):151777. PubMed ID: 34481218
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
Wang JR; Liu B; Zhou L; Huang YX
Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
[TBL] [Abstract][Full Text] [Related]
15. Expression levels and clinical values of miR-92b-3p in breast cancer.
Du Y; Miao Z; Wang K; Lv Y; Qiu L; Guo L
World J Surg Oncol; 2021 Aug; 19(1):239. PubMed ID: 34380511
[TBL] [Abstract][Full Text] [Related]
16. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y
Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801
[TBL] [Abstract][Full Text] [Related]
17. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.
Cui S; Zhang K; Li C; Chen J; Pan Y; Feng B; Lu L; Zhu Z; Wang R; Chen L
Oncotarget; 2016 Nov; 7(47):78009-78028. PubMed ID: 27793005
[TBL] [Abstract][Full Text] [Related]
18. Exosomal miR-22-3p from Mesenchymal Stem Cells Inhibits the Epithelial-Mesenchymal Transition (EMT) of Melanoma Cells by Regulating
Chen Y; Fang Y; Li L; Luo H; Cao T; Tu B
Front Biosci (Landmark Ed); 2022 Sep; 27(9):275. PubMed ID: 36224027
[TBL] [Abstract][Full Text] [Related]
19. The inhibitive effect of sh-HIF1A-AS2 on the proliferation, invasion, and pathological damage of breast cancer via targeting miR-548c-3p through regulating HIF-1α/VEGF pathway in vitro and vivo.
Guo X; Lee S; Cao P
Onco Targets Ther; 2019; 12():825-834. PubMed ID: 30774370
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-124-3p directly targets PDCD6 to inhibit metastasis in breast cancer.
Zhang L; Chen X; Liu B; Han J
Oncol Lett; 2018 Jan; 15(1):984-990. PubMed ID: 29387242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
